MENU
+Compare
BEAT
Stock ticker: NASDAQ
AS OF
Jan 23, 04:59 PM (EDT)
Price
$2.15
Change
+$0.01 (+0.47%)
Capitalization
57.13M

BEAT Heartbeam Forecast, Technical & Fundamental Analysis

a wireless medical technology company, which focuses on the delivery of health information

BEAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BEAT with price predictions
Jan 08, 2025

BEAT's RSI Indicator climbs out of oversold territory

The RSI Indicator for BEAT moved out of oversold territory on December 31, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 16 similar instances when the indicator left oversold territory. In of the 16 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 42 cases where BEAT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BEAT advanced for three days, in of 133 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day moving average for BEAT crossed bearishly below the 50-day moving average on December 27, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BEAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BEAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.586) is normal, around the industry mean (31.428). P/E Ratio (149.254) is within average values for comparable stocks, (158.878). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.763). Dividend Yield (0.000) settles around the average of (0.085) among similar stocks. P/S Ratio (5.999) is also within normal values, averaging (58.898).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BEAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

View a ticker or compare two or three
BEAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BEAT is expected to report earnings to fall 10.53% to -17 cents per share on March 20

Heartbeam BEAT Stock Earnings Reports
Q4'24
Est.
$-0.17
Q3'24
Missed
by $0.04
Q2'24
Missed
by $0.02
Q1'24
Missed
by $0.02
Q4'23
Beat
by $0.19
The last earnings report on November 07 showed earnings per share of -18 cents, missing the estimate of -15 cents. With 53.77K shares outstanding, the current market capitalization sits at 57.13M.
A.I. Advisor
published General Information

General Information

a wireless medical technology company, which focuses on the delivery of health information

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
2118 Walsh Avenue
Phone
+1 408 899-4443
Employees
15
Web
https://www.heartbeam.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARCO7.330.05
+0.69%
Arcos Dorados Holdings
IMMX1.980.01
+0.51%
Immix Biopharma
BCC127.92-1.20
-0.93%
Boise Cascade Company
HRZN9.24-0.11
-1.18%
Horizon Technology Finance Corp
DUK108.82-1.95
-1.76%
Duke Energy Corp

BEAT and Stocks

Correlation & Price change

A.I.dvisor tells us that BEAT and DSGX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BEAT and DSGX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAT
1D Price
Change %
BEAT100%
N/A
DSGX - BEAT
29%
Poorly correlated
+1.59%
LIQQF - BEAT
29%
Poorly correlated
N/A
PDFS - BEAT
28%
Poorly correlated
+0.77%
LYT - BEAT
27%
Poorly correlated
-1.82%
CDNS - BEAT
24%
Poorly correlated
+3.38%
More